Sanford C. Bernstein set a €125.00 ($137.36) target price on Bayer AG (FRA:BAYN) in a research note published on Tuesday, April 18th. The firm currently has a buy rating on the healthcare company’s stock.
Other research analysts have also recently issued research reports about the company. Deutsche Bank AG set a €120.00 ($131.87) target price on Bayer AG and gave the company a buy rating in a research note on Tuesday, January 17th. JPMorgan Chase & Co. reiterated a buy rating on shares of Bayer AG in a report on Thursday, January 12th. Citigroup Inc reiterated a buy rating on shares of Bayer AG in a report on Friday, January 6th. Commerzbank Ag set a €118.00 ($129.67) price target on Bayer AG and gave the company a buy rating in a report on Friday, January 6th. Finally, Jefferies Group LLC set a €115.00 ($126.37) target price on Bayer AG and gave the stock a buy rating in a report on Monday, December 19th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Bayer AG presently has an average rating of Buy and an average price target of €115.43 ($126.84).
Bayer AG (FRA:BAYN) traded up 0.02% during midday trading on Tuesday, hitting €116.80. The stock had a trading volume of 3,259 shares. The company has a market cap of €101.78 billion and a P/E ratio of 19.32. Bayer AG has a 12 month low of €83.87 and a 12 month high of €117.60. The firm’s 50-day moving average price is €110.26 and its 200 day moving average price is €102.35.
COPYRIGHT VIOLATION NOTICE: This story was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://sportsperspectives.com/2017/05/19/bayer-ag-bayn-pt-set-at-125-00-by-sanford-c-bernstein-2-updated-updated-updated.html.
About Bayer AG
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.